Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZLAB · against 363 other Healthcare companies of similar size
Ranked #310 of 364 · scores higher than 13% of peers
Bars: peers in each 10-point band of the profitability score36 peers with a profitability score of 10–19, including ZLAB · Click a bar to see the companies
Mainly because of its return on invested capital, operating margin and return on assets, which are weaker than most Healthcare peers.
| Metric | ZLAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 345 reported | -104.7% | 6.7% | 7% | 33% | |
| Operating marginHigher is better · 336 reported | -58.7% | 8.6% | 12% | 33% | |
| Return on assetsHigher is better · 348 reported | -17.5% | 2.4% | 18% | 33% | |
| Return on equityHigher is better · 337 reported | -26.9% | 5.7% | 22% | Context only | |
| Gross marginHigher is better · 373 reported | 3.8% | 47.6% | 16% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 310 | 1.3B USD | 16 | 30 | |
| 310 | 4.0B USD | 16 | 30 | |
| 310 | 1.6B USD | 16 | 24 | |
| 310 | 1.5B USD | 16 | 39 | |
| 310 | 2.5B USD | 16 | 31 | |
| 317 | 1.7B USD | 15 | 30 | |
| 317 | 1.3B USD | 15 | 29 | |
| 319 | 2.7B USD | 14 | 50 | |
| 319 | 1.7B USD | 14 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score